IN8bio
INAB
29 hedge funds and large institutions have $11.4M invested in IN8bio in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 0 closing their positions.
342% more capital invested
Capital invested by funds: $2.58M → $11.4M (+$8.82M)
38% more funds holding
Funds holding: 21 → 29 (+8)
0.63% more ownership
Funds ownership: 0.26% → 0.89% (+0.63%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$4.37M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$873K |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$691K |
| 4 |
6CM
683 Capital Management
New York
|
+$655K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$83.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Voss Capital
Houston,
Texas
|
-$182K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$163K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$10.7K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.01K |
| 5 |
BlackRock
New York
|
-$927 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $6.22K | -$512 | -16 | -10% |
|
|
27
Wells Fargo
San Francisco,
California
| $218 | -$10.7K | -336 | -99% |
|
28
JP Morgan Chase
New York
| $47 | – | – | – |
|
29
Bank of America
Charlotte,
North Carolina
| $18 | – | – | – |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$160 | +5 | +125% |
|
INAB Hedge Fund Activity: Q4 2023 in Review
29 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in IN8bio (INAB) for Q4 2023, worth a combined $11.4M — up 342% from $2.58M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new INAB positions and 0 closed out — a net gain of 8 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $4.37M. The largest seller was Voss Capital, cutting an estimated $182K.
- 29 institutional investors held IN8bio (INAB) as of Q4 2023, up from 21 in Q3 2023.
- Funds reported $11.4M of IN8bio stock for Q4 2023, up 342% quarter-over-quarter.
- 8 funds opened new IN8bio positions in Q4 2023 and 0 closed out, a net change of +8 holders.
- The largest IN8bio buyer in Q4 2023 was AIGH Capital Management, an estimated $4.37M added.
- The largest IN8bio seller in Q4 2023 was Voss Capital, an estimated $182K sold.
Based on aggregated 13F filings for Q4 2023.